BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37381169)

  • 21. RAS protein activator like 2 promotes the proliferation and migration of pulmonary artery smooth muscle cell through AKT/mammalian target of Rapamycin complex 1 pathway in pulmonary hypertension.
    Hu S; Zhao Y; Qiu C; Li Y
    Bioengineered; 2022 Feb; 13(2):3516-3526. PubMed ID: 35044284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of polycomb repressor complex 2 ameliorates neointimal hyperplasia by suppressing trimethylation of H3K27 in vascular smooth muscle cells.
    Liang J; Li Q; Cai W; Zhang X; Yang B; Li X; Jiang S; Tian S; Zhang K; Song H; Ai D; Zhang X; Wang C; Zhu Y
    Br J Pharmacol; 2019 Sep; 176(17):3206-3219. PubMed ID: 31162630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semaphorin-3A protects against neointimal hyperplasia after vascular injury.
    Wu JH; Zhou YF; Hong CD; Chen AQ; Luo Y; Mao L; Xia YP; He QW; Jin HJ; Huang M; Li YN; Hu B
    EBioMedicine; 2019 Jan; 39():95-108. PubMed ID: 30579864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Semaphorin-3E attenuates neointimal formation via suppressing VSMCs migration and proliferation.
    Wu JH; Li Y; Zhou YF; Haslam J; Elvis ON; Mao L; Xia YP; Hu B
    Cardiovasc Res; 2017 Dec; 113(14):1763-1775. PubMed ID: 29016743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opposing Actions of AKT (Protein Kinase B) Isoforms in Vascular Smooth Muscle Injury and Therapeutic Response.
    Jin Y; Xie Y; Ostriker AC; Zhang X; Liu R; Lee MY; Leslie KL; Tang W; Du J; Lee SH; Wang Y; Sessa WC; Hwa J; Yu J; Martin KA
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2311-2321. PubMed ID: 29025710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukotriene-C4 synthase, a critical enzyme in the activation of store-independent Orai1/Orai3 channels, is required for neointimal hyperplasia.
    Zhang W; Zhang X; González-Cobos JC; Stolwijk JA; Matrougui K; Trebak M
    J Biol Chem; 2015 Feb; 290(8):5015-5027. PubMed ID: 25540197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ruxolitinib attenuates intimal hyperplasia via inhibiting JAK2/STAT3 signaling pathway activation induced by PDGF-BB in vascular smooth muscle cells.
    Song HT; Cui Y; Zhang LL; Cao G; Li L; Li G; Jia XJ
    Microvasc Res; 2020 Nov; 132():104060. PubMed ID: 32818511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular injury activates the ELK1/SND1/SRF pathway to promote vascular smooth muscle cell proliferative phenotype and neointimal hyperplasia.
    Su C; Liu M; Yao X; Hao W; Ma J; Ren Y; Gao X; Xin L; Ge L; Yu Y; Wei M; Yang J
    Cell Mol Life Sci; 2024 Jan; 81(1):59. PubMed ID: 38279051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WWC3 inhibits intimal proliferation following vascular injury via the Hippo signaling pathway.
    Chen B; Liu G
    Mol Med Rep; 2018 Apr; 17(4):5175-5183. PubMed ID: 29393412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effects of scoparone from chestnut inner shell on platelet-derived growth factor-BB-induced vascular smooth muscle cell migration and vascular neointima hyperplasia.
    Jung SH; Lee GB; Ryu Y; Cui L; Lee HM; Kim J; Kim B; Won KJ
    J Sci Food Agric; 2019 Jul; 99(9):4397-4406. PubMed ID: 30861122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of polypyrimidine tract-binding protein 1/yin yang 2 signaling in regulating vascular smooth muscle cell proliferation and neointima hyperplasia.
    Wang Z; Gan X; Qiu C; Yang D; Sun X; Zeng Z
    Toxicol Appl Pharmacol; 2019 Nov; 383():114747. PubMed ID: 31499192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficiency of thrombospondin-2 alleviates intimal hyperplasia in mice by modulating vascular smooth muscle cell proliferation and migration.
    Li X; Ding Y; Zhou M; Zhou Z; Xie T; Wang Y; Liu Z; Si Y; Shi Z
    FASEB J; 2023 Feb; 37(2):e22743. PubMed ID: 36645109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NCK Associated Protein 1 Modulated by miRNA-214 Determines Vascular Smooth Muscle Cell Migration, Proliferation, and Neointima Hyperplasia.
    Afzal TA; Luong LA; Chen D; Zhang C; Yang F; Chen Q; An W; Wilkes E; Yashiro K; Cutillas PR; Zhang L; Xiao Q
    J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 27927633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of mitochondrial complex I activity attenuates neointimal hyperplasia by inhibiting smooth muscle cell proliferation and migration.
    Yin J; Xia W; Wu M; Zhang Y; Huang S; Zhang A; Jia Z
    Chem Biol Interact; 2019 May; 304():73-82. PubMed ID: 30857887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of PCK2 in the proliferation of vascular smooth muscle cells in neointimal hyperplasia.
    Ko DS; Kang J; Heo HJ; Kim EK; Kim K; Kang JM; Jung Y; Baek SE; Kim YH
    Int J Biol Sci; 2022; 18(13):5154-5167. PubMed ID: 35982907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plin5 inhibits proliferation and migration of vascular smooth muscle cell through interacting with PGC-1α following vascular injury.
    Gan X; Zhao J; Chen Y; Li Y; Xuan B; Gu M; Feng F; Yang Y; Yang D; Sun X
    Bioengineered; 2022 Apr; 13(4):10665-10678. PubMed ID: 35470759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suv39h1 downregulation inhibits neointimal hyperplasia after vascular injury.
    Zhang J; Chen J; Yang J; Xu C; Hu Q; Wu H; Cai W; Guo Q; Gao W; He C; Yang C; Yang J
    Atherosclerosis; 2019 Sep; 288():76-84. PubMed ID: 31330382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleotide-binding oligomerization domain protein 2 deficiency enhances neointimal formation in response to vascular injury.
    Kwon MY; Liu X; Lee SJ; Kang YH; Choi AM; Lee KU; Perrella MA; Chung SW
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2441-7. PubMed ID: 21903945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isoxanthohumol reduces neointimal hyperplasia through the apelin/AKT pathway.
    Chang TY; Lin MS; Chen CC; Leu YL; Wang SH
    Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167099. PubMed ID: 38428686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1.
    Li P; Liu Y; Yi B; Wang G; You X; Zhao X; Summer R; Qin Y; Sun J
    Cardiovasc Res; 2013 Jul; 99(1):185-93. PubMed ID: 23554459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.